Publications by authors named "Long-Long Gao"

Claim this Profile
G
Guselkumab for Moderate to Severe Scalp Psoriasis Across All Skin Tones: Cohort B of the VISIBLE Randomized Clinical Trial.
Amy McMichael, Mona Shahriari, Linda Stein Gold, Theodore Alkousakis, Olivia Choi, Long-Long Gao

JAMA Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guselkumab for Moderate to Severe Psoriasis Across All Skin Tones: Cohort A of the VISIBLE Randomized Clinical Trial.
Andrew Alexis, Amy McMichael, Jennifer Soung, Olivia Choi, Theodore Alkousakis, Long-Long Gao

JAMA Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPECTREM Phase 3b Clinical Trial Results Through Week 16: Guselkumab Efficacy and Safety for the Treatment of Low Body Surface Area, Moderate Psoriasis With High-Impact Site Involvement.
Linda Stein Gold, Alice B Gottlieb, April W Armstrong, Theodore Alkousakis, Robert Bissonnette, Long-Long Gao

Br J Dermatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Diversity in a Novel Psoriasis Study: VISIBLE as a Framework for Clinical Trial Quality Improvement.
Andrew Alexis, Amy McMichael, Neelam Vashi, Tina Bhutani, Adrian O Rodriguez, Long-Long Gao

JAMA Dermatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn's Disease.
Jean-Frédéric Colombel, Bruce E Sands, Christopher Gasink, Benjamin Yeager, Omoniyi J Adedokun, Long-Long Gao

Clin Gastroenterol Hepatol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Cloning and functional characterization of two oxidosqualene cyclase genes from Siraitia grosvenorii].
Hai-Yun Gao, Long-Long Gao, Yuan Liu, Huan Zhao, Wei Gao

Zhongguo Zhong Yao Za Zhi· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ustekinumab Therapeutic Drug Monitoring-Impact on Clinical Practice: A Multicenter Cross-Sectional Observational Trial.
Waqqas Afif, Bernie Sattin, Dorota Dajnowiec, Reena Khanna, Cynthia H Seow, Long-Long Gao

Dig Dis Sci· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial.
Bruce E Sands, Peter M Irving, Timothy Hoops, James L Izanec, Long-Long Gao

Lancet· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination Therapy With Infliximab and Azathioprine Improves Infliximab Pharmacokinetic Features and Efficacy: A Post Hoc Analysis.
Jean-Frédéric Colombel, Omoniyi J Adedokun, Christopher Gasink, Long-Long Gao, Freddy J Cornillie

Clin Gastroenterol Hepatol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effects of Ustekinumab on Health-related Quality of Life in Patients With Moderate to Severe Crohn's Disease.
Bruce E Sands, Chenglong Han, Christopher Gasink, Douglas Jacobstein, Philippe Szapary, Long-Long Gao

J Crohns Colitis· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease.
Omoniyi J Adedokun, Zhenhua Xu, Christopher Gasink, Douglas Jacobstein, Philippe Szapary, Long-Long Gao

Gastroenterology· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
Brian G Feagan, William J Sandborn, Christopher Gasink, Douglas Jacobstein, Yinghua Lang, Long-Long Gao

N Engl J Med· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
William J Sandborn, Christopher Gasink, Long-Long Gao, Marion A Blank, Jewel Johanns

N Engl J Med· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis